Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
06/11/2025
Fitch has rated the new senior unsecured bonds issued by the global payment company as "BBB".
Latest
2 m ago
Analysts point out that the P/E ratio and other valuation indicators of the S&P 500 have reached levels close to those of the Internet bubble period.
3 m ago
According to reports, the U.S. Treasury Department has sanctioned individuals who "exploited loopholes in currency exchange facilities in Lebanon to facilitate Iran's transfer of tens of millions of dollars to Hezbollah by 2025."
5 m ago
In early trading on Thursday, shares of U.S. cosmetics producer e.l.f. Beauty plummeted by 33%, after the company reported that its performance guidance for the fiscal year 2026 did not meet expectations and profits were impacted by new U.S. tariffs, despite second-quarter earnings per share exceeding expectations and growth from the Rhode brand contributing.
5 m ago
An American judge dismissed the criminal case against Boeing company over two 737 Max airplane crashes.
7 m ago
In the early trading on Thursday, Pfizer rose 0.5% while Novo Nordisk fell 3%. It was reported that after Novo Nordisk raised its offer to acquire the obesity biotech company Metsera to $10 billion, Pfizer also made a matching offer, raising the valuation to $10 billion, escalating the acquisition competition in the GLP-1 drug field. Metsera, the target of the acquisition, surged 10.5% in early trading on Thursday.
See all latest